Philippe brings over 30 years of pharmaceutical industry expertise to ProTransit, with a deep understanding of market dynamics, stakeholder engagement, and early-stage commercialization. Known for his strategic, value-driven approach, Philippe has led major product launches and divisions at blue chip pharma companies and start-ups. His experience includes Rogaine® at Pharmacia & Upjohn, launching Xenical® (orlistat,Continue reading “Philippe Burnham”
Department Archives
Brady Stillman, Ph.D.
Dr. Stillman is a key consultant to ProTransit, overseeing the production of the company’s Pro-MP™ delivery technology. With extensive experience in GLP and cGMP-compliant manufacturing environments, Brady manages both pre-production and final production processes to ensure quality control and regulatory adherence. Brady is affiliated with the University of Nebraska College of Medicine, Department of PharmacologyContinue reading “Brady Stillman, Ph.D.”
Tommy Stormberg, Ph.D.
Dr. Stormberg comes to ProTransit as a consultant scientist with a strong background in R&D, process development, and scientific documentation. He earned both his Ph.D. in Pharmaceutical Sciences and B.S. in Biomedical Physics from the University of Nebraska Medical Center. With a focus on translating scientific innovation into effective therapeutic products, Tommy brings expertise inContinue reading “Tommy Stormberg, Ph.D.”
Vinod Labhasetwar, Ph.D.
Dr. Labhasetwar is a Professor of Biomedical Engineering at the Lerner Research Institute, Cleveland Clinic, with expertise in translational and clinical nanomedicine focused on cancer, CNS injuries, and cardiovascular diseases. His current research includes nanoparticle-based drug and gene delivery for cancer treatment and detection, antioxidant enzyme therapy for stroke and spinal cord injury, and vascular-targetedContinue reading “Vinod Labhasetwar, Ph.D.”
Gary Madsen, Ph.D.
Dr. Madsen brings more than 30 years of experience in developing and commercializing biotechnology products across diverse markets and company stages. He spent 17 years at Abbott Laboratories leading product support, new product development, and business development initiatives. He later served as Vice President of R&D at IDEXX Laboratories in Westbrook, ME. Dr. Madsen hasContinue reading “Gary Madsen, Ph.D.”